Synapse - Brian Kushner

Results (233)

High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM)

Meeting Abstract

Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma

Journal Article

Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

Reduced-dose radiation therapy to the primary site is effective for high-risk neuroblastoma: Results from a prospective trial

Journal Article

Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; Roberts, S. S.; LaQuaglia, M. P.; Wolden, S. L.
International Journal of Radiation Oncology, Biology, Physics (2019)

Fulltext@MSK | Save

Impact of disease site, size and surgical resection on survival from metastatic CNS neuroblastoma

Meeting Abstract

Kramer, K.; Haque, S.; Wolden, S.; Greenfield, J.; Kushner, B.; Modak, S.; Cheung, N. K.; Donzelli, M.; Eljalby, M.; Souweidane, M.
Neuro-Oncology (2018)

Fulltext@MSK | Save

Humanized 3F8 anti-G(D2) monoclonal antibody dosing with granulocyte-macrophage colony-stimulating factor in patients with resistant neuroblastoma: A phase 1 clinical trial

Journal Article

Kushner, B. H.; Cheung, I. Y.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K.
JAMA Oncology (2018)

Fulltext@MSK | Save

Assessment of late pulmonary outcomes and exercise capacity among pediatric survivors of high-risk neuroblastoma

Meeting Abstract

Stone, A. E.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Veler, H.; Wu, X.; Cheung, N.; more...
American Journal of Respiratory and Critical Care Medicine (2018)

Fulltext@MSK | Save

Intraventricular 131I-labeled monoclonal antibody 8H9 (omburtomab) targeting the surface glycoprotein B7-H3 in patients with CNS malignancies

Meeting Abstract

Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Tomlinson, U.; Donzelli, M.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
Pediatric Blood and Cancer (2018)

Fulltext@MSK | Save

Local control with reduced-dose radiation therapy for high-risk neuroblastoma: 3-year results from a prospective trial

Meeting Abstract

Casey, D.; Kushner, B.; Cheung, N. K.; Modak, S.; La Quaglia, M.; Wolden, S.
Pediatric Blood and Cancer (2018)

Fulltext@MSK | Save

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study

Journal Article

Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
OncoImmunology (2018)

Fulltext@MSK | Save

Treatment and outcome of adult-onset neuroblastoma

Journal Article

Suzuki, M.; Kushner, B. H.; Kramer, K.; Basu, E. M.; Roberts, S. S.; Hammond, W. J.; LaQuaglia, M. P.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
International Journal of Cancer (2018)

Fulltext@MSK | Save